| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
31,095 |
28,769 |
$2.83M |
| 99222 |
Initial hospital care, per day, moderate complexity |
12,771 |
12,714 |
$1.39M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,449 |
21,177 |
$1.35M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,458 |
3,458 |
$300K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
3,887 |
2,595 |
$170K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,784 |
2,763 |
$108K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
800 |
799 |
$106K |
| 99215 |
Prolong outpt/office vis |
450 |
436 |
$64K |
| 99205 |
Prolong outpt/office vis |
334 |
334 |
$58K |
| 99350 |
Prolong home eval add 15m |
927 |
891 |
$49K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
439 |
438 |
$44K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,039 |
992 |
$40K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
373 |
373 |
$34K |
| 80050 |
General health panel |
863 |
861 |
$26K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
213 |
208 |
$17K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
179 |
179 |
$16K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
367 |
364 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
819 |
785 |
$12K |
| 99442 |
|
249 |
217 |
$10K |
| 84481 |
|
625 |
622 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
177 |
173 |
$9K |
| 72110 |
|
246 |
246 |
$7K |
| 73630 |
|
256 |
251 |
$7K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
17 |
17 |
$7K |
| 84439 |
|
641 |
637 |
$5K |
| 80061 |
Lipid panel |
413 |
412 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
127 |
122 |
$5K |
| 99441 |
|
115 |
94 |
$4K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
183 |
183 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
225 |
221 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
555 |
546 |
$3K |
| 80305 |
|
278 |
275 |
$3K |
| 73610 |
|
96 |
94 |
$3K |
| 99490 |
Ccm add 20min |
450 |
450 |
$3K |
| 95816 |
|
12 |
12 |
$3K |
| 99223 |
Prolong inpt eval add15 m |
27 |
27 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
82 |
79 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
51 |
49 |
$3K |
| 80053 |
Comprehensive metabolic panel |
287 |
283 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
40 |
40 |
$2K |
| 90686 |
|
828 |
828 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
242 |
241 |
$2K |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
301 |
301 |
$2K |
| 99443 |
|
16 |
16 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
218 |
213 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
86 |
86 |
$1K |
| 99406 |
|
108 |
104 |
$1K |
| 99337 |
|
68 |
61 |
$1K |
| G0181 |
Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans |
154 |
154 |
$1K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
12 |
12 |
$1K |
| 99349 |
|
32 |
32 |
$1K |
| 73560 |
|
27 |
27 |
$728.64 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
29 |
28 |
$702.18 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
193 |
165 |
$518.50 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
100 |
98 |
$509.78 |
| 73562 |
|
12 |
12 |
$418.62 |
| 81025 |
|
53 |
53 |
$383.22 |
| 96127 |
|
62 |
62 |
$210.86 |
| 99457 |
|
33 |
33 |
$185.92 |
| 85027 |
|
27 |
27 |
$155.97 |
| 99152 |
|
27 |
26 |
$85.12 |
| 87081 |
|
12 |
12 |
$70.80 |
| 99421 |
|
26 |
25 |
$25.63 |
| 90685 |
|
15 |
15 |
$0.15 |
| 96160 |
|
1,230 |
1,226 |
$0.00 |
| 90670 |
|
78 |
78 |
$0.00 |
| 90715 |
|
15 |
15 |
$0.00 |
| 90633 |
|
12 |
12 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
15 |
15 |
$0.00 |
| 90649 |
|
67 |
67 |
$0.00 |
| 90734 |
|
46 |
46 |
$0.00 |
| 90700 |
|
12 |
12 |
$0.00 |
| 90647 |
|
77 |
77 |
$0.00 |